Immune System Crosstalk, Engineering Innovative Biomaterials & Immunotherapies

University of Pennsylvania & Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

The MA LAB for immune engineering and translational immunology at the University of Pennsylvania and Children’s Hospital of Philadelphia is seeking talented and dedicated post-doctoral fellows to join our innovative laboratory to carry out cutting-edge research on immune system crosstalk and engineer innovative biomaterials, protein and cell-based immunotherapies.

We are a highly interdisciplinary team working at the interface of immunology and engineering. We leverage 1) Chemical and biomaterials engineering to dissect and manipulate immune cell-cell and cell-tissue crosstalk to enhance cellular therapy and promote vaccine development, 2) Genetic engineering and synthetic immunology to create intelligent cells that integrate environmental cues for decision making, 3) Protein engineering to develop safe and potent immune-modulatory proteins and nanostructures with desired trafficking profile, release kinetics, enhanced or novel functions.

Candidates should have a PhD and/or MD (or equivalent) degree in biomedical sciences or bioengineering. Ideal candidates will be self-motivated, possess strong problem solving and critical thinking skills and have the ability to work independently, exercise discretion and communicate effectively. We are currently seeking candidates with experience in immunology, molecular biology, genomics or genetic engineering. 

Successful candidates will benefit from the thriving and collegial UPenn/CHOP research community, tailored career development guidance, state-of-the-art research facilities and excellent benefits package.

Applicants should send their inquiries to

(

; 

, please send email to both addresses!) along with a CV, contacts for three references and a brief summary of research experience and interests.

Research environment: UPenn/CHOP is featured by its unique geographical unity, where a top-ranking medical school, engineering school, and research hospital are closely connected on a single campus, fostering tremendous opportunities for cross-departmental collaboration and interdisciplinary research. UPenn/CHOP is an international leader in cell and gene therapy research and has established state-of-the-art GMP facilities for viral vector and therapeutic cell manufacturing. The Ma lab is a member of the Abramson Cancer Center, the Raymond G. Perelman Center for Cellular and Molecular Therapeutics, the Center for Cellular Immunotherapy and the Parker Institute for Cancer Immunotherapy. Here, we are perfectly positioned to bring our research from bench to bedside at an unprecedented pace.

Our mission is to transform human healthcare by performing cutting-edge translational research. Together, with our dedication, the cure is within reach!